BR112015001174A2 - composições para tratamento de fadiga relacionada ao câncer - Google Patents

composições para tratamento de fadiga relacionada ao câncer

Info

Publication number
BR112015001174A2
BR112015001174A2 BR112015001174A BR112015001174A BR112015001174A2 BR 112015001174 A2 BR112015001174 A2 BR 112015001174A2 BR 112015001174 A BR112015001174 A BR 112015001174A BR 112015001174 A BR112015001174 A BR 112015001174A BR 112015001174 A2 BR112015001174 A2 BR 112015001174A2
Authority
BR
Brazil
Prior art keywords
cancer
treatment compositions
fatigue treatment
related fatigue
compositions
Prior art date
Application number
BR112015001174A
Other languages
English (en)
Other versions
BR112015001174B1 (pt
Inventor
Bombardelli Ezio
Corti Fabrizio
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of BR112015001174A2 publication Critical patent/BR112015001174A2/pt
Publication of BR112015001174B1 publication Critical patent/BR112015001174B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

resumo patente de invenção: "composições para tratamento de fadiga relacionada ao câncer". a presente invenção refere-se a composições que contém extratos de (a) panax ginseng c.a. mayer, (b) zingiber officinale, (c) echinacea angustifolia e (d) silybum marianum ou o complexo fosfolipídio de silibinina com fosfolipídios como ingredientes ativos, em mistura com excipientes apropriados.
BR112015001174-8A 2012-07-27 2013-07-11 composições para tratamento de fadiga relacionada ao câncer BR112015001174B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT001317A ITMI20121317A1 (it) 2012-07-27 2012-07-27 Composizioni per il trattamento della fatica oncologica
ITMI2012A001317 2012-07-27
PCT/EP2013/064711 WO2014016137A1 (en) 2012-07-27 2013-07-11 Compositions for treatment of cancer-related fatigue

Publications (2)

Publication Number Publication Date
BR112015001174A2 true BR112015001174A2 (pt) 2017-06-27
BR112015001174B1 BR112015001174B1 (pt) 2021-02-02

Family

ID=46939795

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015001174-8A BR112015001174B1 (pt) 2012-07-27 2013-07-11 composições para tratamento de fadiga relacionada ao câncer

Country Status (22)

Country Link
US (1) US9566309B2 (pt)
EP (1) EP2877192B1 (pt)
JP (1) JP6129314B2 (pt)
KR (1) KR102091128B1 (pt)
CN (1) CN104540514B (pt)
AU (1) AU2013295227B2 (pt)
BR (1) BR112015001174B1 (pt)
CA (1) CA2879906A1 (pt)
DK (1) DK2877192T3 (pt)
ES (1) ES2590209T3 (pt)
HK (1) HK1209375A1 (pt)
HR (1) HRP20160774T1 (pt)
HU (1) HUE030002T2 (pt)
IL (1) IL236871B (pt)
IN (1) IN2015KN00222A (pt)
IT (1) ITMI20121317A1 (pt)
PL (1) PL2877192T3 (pt)
PT (1) PT2877192T (pt)
RU (1) RU2631612C2 (pt)
SG (1) SG11201500521XA (pt)
SI (1) SI2877192T1 (pt)
WO (1) WO2014016137A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105658227B (zh) * 2013-08-30 2020-04-03 绿十字生命健康有限公司 含有人参皂苷成分得到增加的加工人参粉末或加工人参提取物的用于预防及治疗癌因性疲乏的组合物
EP3389644B1 (en) * 2015-12-16 2022-01-26 Parachur, Vivek Anand Tri-molecular complex of natural compounds
EP3335716A1 (en) * 2016-12-15 2018-06-20 Indena S.p.A. Process for the preparation of powder compositions
AU2022277553A1 (en) 2021-05-18 2023-11-09 Prostasis, Llc Compositions comprising mixtures of compounds and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1215291B (it) * 1985-07-17 1990-01-31 Inverni Della Beffa Spa Complessi di flavanolignani con fosfolipidi, loro preparazione e relative composizioni farmaceutiche.
ATE123947T1 (de) 1990-07-05 1995-07-15 Indena Spa Echinacea-extrakte, verfahren zur herstellung und zubereitungen, die sie enthalten.
CZ292832B6 (cs) * 2001-08-30 2003-12-17 Ivax Pharmaceuticals S.R.O. Způsob přípravy silymarinu se zvýšenou rozpustností
US20030206978A1 (en) * 2001-11-29 2003-11-06 Bob Sherwood Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
US20050002962A1 (en) * 2003-04-16 2005-01-06 David Pasco Immunostimulatory agents in botanicals
US20050031710A1 (en) * 2003-08-08 2005-02-10 D'adamo Peter James Method of personal care and cosmetic product preparation and composition using human blood type
RU2277927C2 (ru) * 2004-09-15 2006-06-20 Наталья Ивановна Весельева Лечебно-профилактический комплекс "бальзам долголетие" общеукрепляющего и тонизирующего действия (варианты)
ITMI20090049A1 (it) * 2009-01-20 2010-07-21 Indena Spa Composizioni a base di estratti lipofili di zingiber officinale e di echinacea angustifolia per la prevenzione e il trattamento del riflusso gastro-esofageo e dell'emesi indotta da chemioterapici
CN101502320B (zh) * 2009-03-11 2012-09-05 王越 一种参姜红枣饮料冲剂的生产方法
IT1401141B1 (it) * 2010-07-26 2013-07-12 Indena Spa Formulazioni contenenti estratti di echinacea angustifolia e di zingiber officinale utili nella riduzione dell'infiammazione e del dolore periferico

Also Published As

Publication number Publication date
JP6129314B2 (ja) 2017-05-17
ITMI20121317A1 (it) 2014-01-28
AU2013295227A1 (en) 2015-02-19
IN2015KN00222A (pt) 2015-06-12
KR20150037890A (ko) 2015-04-08
CA2879906A1 (en) 2014-01-30
BR112015001174B1 (pt) 2021-02-02
CN104540514A (zh) 2015-04-22
SI2877192T1 (sl) 2016-09-30
ES2590209T3 (es) 2016-11-18
DK2877192T3 (en) 2016-09-05
PL2877192T3 (pl) 2016-12-30
AU2013295227B2 (en) 2017-04-27
WO2014016137A1 (en) 2014-01-30
KR102091128B1 (ko) 2020-03-20
SG11201500521XA (en) 2015-02-27
US20150202246A1 (en) 2015-07-23
EP2877192A1 (en) 2015-06-03
PT2877192T (pt) 2016-09-13
RU2015102002A (ru) 2016-09-20
HUE030002T2 (en) 2017-04-28
IL236871B (en) 2018-01-31
EP2877192B1 (en) 2016-06-08
US9566309B2 (en) 2017-02-14
HRP20160774T1 (hr) 2016-08-12
JP2015522631A (ja) 2015-08-06
HK1209375A1 (en) 2016-04-01
CN104540514B (zh) 2020-03-27
RU2631612C2 (ru) 2017-09-25

Similar Documents

Publication Publication Date Title
BR112015011171A2 (pt) compostos de pirrolopirimidina como inibidores da quinase
BR112018001640A2 (pt) combinação de antagonista da pd-1 com um inibidor de egfr
BR112013001838A2 (pt) formulações contendo extratos de echinacea angustifólia e zingiber officinale que são úteis na redução de inflamação e dor periférica
BR112015007985A8 (pt) uso do carboidrato galactose denteada para preparação de composições para tratamento de nefropatia diabética e de distúrbios associados, e suas composições
BR112017018368A2 (pt) composições contendo rna para o tratamento de doenças tumorais
WO2015009726A3 (en) Medical uses of cd38 agonists
SG10201808102WA (en) Bicyclic heterocycle compounds and their uses in therapy
AR093181A1 (es) Formulacion con contenido de enzimas digestivas bajo estable
BR112013018920A2 (pt) composições de nanopartículas, formulações destas e seus usos
MX360045B (es) Combinaciones farmacéuticas de un inhibidor de cdk4/6 y un inhibidor de b-raf.
BR112015027282A8 (pt) formulação líquida e kit compreendendo fenfluramina, e usos da mesma no tratamento de síndrome de dravet
BR112015010663A2 (pt) formas de dosagem de ruxolitinib de liberação sustentada
BR112014018728A8 (pt) Compostos de purinonas como inibidores de quinase
BR112016012410A2 (pt) conjugado de droga e anticorpo, composto conjugado de droga e anticorpo, composto não-peptídico, método de tratamento de doenças em seres humanos e composição farmacêutica
GB201200062D0 (en) Estradiol oromucosal liquid compositions
BRPI1010861A8 (pt) métodos para tratamento de dor, inflamação ou osteoartrite, pacote e formulação farmacêutica
BR112017009552A8 (pt) Métodos para alvejar o controle transcricional em regiões de super-realçador
PH12015501913A1 (en) Substituted imidazopyridazines
BR112019008384A2 (pt) composição farmacêutica, processos para tratamento e seus usos
CY1119633T1 (el) Νεες φαρμακοτεχνικες μορφες αποτελουμενες απο φυτικα εκχυλισματα
BR112018076639A2 (pt) quimioterapias de combinação
MX2018000546A (es) Composiciones farmaceuticas que contienen celecoxib y tramadol.
BR112015001174A2 (pt) composições para tratamento de fadiga relacionada ao câncer
BR112015010039A2 (pt) tratamento de câncer com pomalidomida em um individuo com disfunção renal
BR112015000321A2 (pt) formulações de laquinimod sem agente alcalinizante

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/07/2013, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 9A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2678 DE 03-05-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.